Report: hoarding of corona vaccine in rich countries affects poor countries



[ad_1]

The World Health Organization (WHO) warned of “vaccine nationalism” and called for cooperation and solidarity among the countries of the world to stop the corona pandemic.

To counter hoarding, WHO launched the Covax (Vaccines Global Access Facility) global vaccine agreement, which will provide a fair distribution of future vaccines. To date, 189 countries have joined, including EU member states.

Now the People’s Vaccine Alliance states: an international association of voluntary organizations including Amnesty International and Oxfam, that solidarity from the rich part of the world weighs lightly.

According to their report, rich countries have been involved in intense hoarding in recent months. These are bilateral deals worth many billions made by a handful of countries, according to the Duke Center for Global Health Innovation database. In the last week alone, countries have bought covid-19 vaccines that are enough to vaccinate their populations three times more.

Richard Bergström, Vaccine Coordinator for Sweden.

Richard Bergström, Vaccine Coordinator for Sweden.

Photo: Stina Stjernkvist / TT

Richard Bergström believes that this is a misunderstanding and a lack of information.

– The report is tremendously misleading and misleading. I am notably upset that the EU has done a lot to make Covax work. We will not vaccinate everyone three times. The idea is that the surplus vaccine is sent to Covax, he says.

But the logistics implementation process at Covax has taken longer and more complex than expected.

– We have been to Covax about where we should send the vaccine. What we are acquiring now is not just for our own people. What we will not use, we must not store or throw away. It should be shipped to other countries immediately after manufacture.

The structure of the population of different countries. it will affect the distribution of the covid vaccine in terms of priority groups, which may reach an unfair percentage. For example, Europe has significantly more older people, people at risk and more health and care staff compared to many low-income countries.

Richard Bergström still believes that a solution will be found and that the EU’s expertise in both procurement and logistics will be used to distribute a future vaccine in low-income countries. That part has not been tampered with yet either.

[ad_2]